시장보고서
상품코드
1193199

혈류 전환기 시장 : 유형별, 용도별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

Flow Diverters Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 301 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 혈류 전환기 시장은 2021년에 2억 5140만 달러, 2031년에는 10억 4190만 달러에 이르며 2022년부터 2031년에 걸쳐 CAGR 15.3%를 기록할 것으로 예측됩니다.

뇌동맥류 또는 두개내 동맥류는 혈관벽 내부의 근육층(내막)의 약화로 인한 뇌동맥의 비정상적인 국소 확장이다. 뇌동맥류의 치료에는 서퍼스 혈류 전환기, 실크 혈류 전환기, 파이프라인 색전기 등의 혈류 전환기가 개발되고 있습니다. 이 혈관 내유치 장치는 동맥류 가방에 묻히는 대신 친동맥에 넣어 사용합니다. 동맥류와 모혈관의 접합부에서 혈행 동태의 변화를 이용하여 시간이 지남에 따라 동맥류의 혈전증을 진행시킨다. 부모 혈관의 루멘은 후속 염증 반응, 치유 및 동맥류를 줄이는 내피의 발달의 결과로 천연 가지와 측면 가지와 함께 보통 온존합니다. 기존에는 치료가 어려웠던 광경부 동맥류와 거대동맥류도 혈류 전환기를 사용하여 치료가 가능합니다.

혈류 전환기 시장은 뇌동맥류의 유병률의 증가와 고혈압의 유병률의 상승이 요인이 되고 있습니다. 게다가 혈류 전환기에 관한 제품의 상시 및 제품 승인의 증가가 혈류 전환기 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 2020년 8월 미국에서는 의료기기 제조회사인 스트라이커사가 'Surpass Evolve Flow Diverter'의 발매를 발표했습니다. 이것은 64개의 코발트 크롬으로 만들어진 유동 다이버터입니다. 이 승인은 회사의 신경 혈관 부문 확대 및 지리적 존재 향상에 기여할 것으로 보입니다. 또한 뇌동맥류의 치료에는 혈류 전환기가 사용되므로 뇌동맥류의 유병률 증가가 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 미국 국립신경질환연구소(National Institute of Neurological Disorders and Stroke)에 따르면 모든 뇌동맥류는 파열되어 뇌내와 주위에 출혈을 일으킬 수 있다고 보고되었습니다. 연간 약 3만명의 미국인이 뇌동맥류 파열로 고통받고 있습니다. 또한 혈류 전환기 시장의 주요 기업에 의한 협업, 인수, 파트너십, 계약 등 주요 전략의 채용이 증가하여 시장 성장에 박차가 걸릴 것으로 예상됩니다. 또한 의료 분야에서의 기술 진보와 의료 관광의 증가는 혈류 전환기 시장의 성장을 촉진할 것으로 예상됩니다. 게다가 저침습 수술에 대한 사람들의 의식 증가와 신흥국의 가처분 소득 증가가 혈류 전환기 시장의 성장을 뒷받침할 것으로 예상됩니다.

노년 인구는 정형 외과 질환, 당뇨병, 낙하로 인한 부상을 입기 쉽습니다. 이 질병은 고통의 유병률을 증가시킵니다. 따라서, 노년 인구 수의 증가는 뇌동맥류의 치료를 위한 흐름 다이버터의 수요를 증가시킨다. 따라서, 이러한 요인은 흐름 다이버터 시장의 성장을 촉진하는 데 기여하고 있습니다. 또한 세계 각국의 정부는 헬스케어 분야에 대한 지출을 늘리고 있습니다. 예를 들어, Medicare & Medicaid Service Center에 따르면 미국 의료비는 2019년부터 2020년까지 9.7% 성장하여 4조 1,000억 달러(1인당 12,530달러)에 이르렀습니다. 마찬가지로 국가 통계국의 발표에 따르면 영국의 의료비 총액은 2019년 국내총생산(GDP)의 10.2%에 비해 2020년에는 12.8%를 차지하게 되었다. 게다가 건강 관리 지출의 약 30%는 의료 인프라, 특히 공중 보건 센터(병원)에서 사용되는 의료 기기를 업그레이드하는 데 사용되는 것으로 추정됩니다. 따라서 이러한 세계 건강 관리 지출의 증가는 다른 질병 치료에서 인혈류 전환기 애플리케이션의 수요를 촉진하여 시장 성장을 추진할 것으로 예상됩니다.

한편, 혈류 전환기와 관련된 부작용이나 혈류 전환기의 고비용이 혈류 전환기 시장의 성장을 억제할 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석
  • 특허 상황

제4장 플로 다이버 시장 : 유형별

  • 개요
    • 시장 규모·예측
  • 파이프라인 색전 장치
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 실크 혈류 전환기
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 서퍼스 혈류 전환기
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 플로리다이렉트 엔드 루미널 디바이스
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제5장 플로 다이버 시장 : 용도별

  • 개요
    • 시장 규모·예측
  • 뇌동맥류
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 다발성 두개내 동맥류
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
    • 다발성 두개내 동맥류 혈류 전환기 시장 : 부위별
      • 안동맥 시장 규모·예측 : 지역별
      • 중대뇌동맥시장 규모·예측 : 지역별
      • 후교통동맥시장 규모·예측 : 지역별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 혈류 전환기 시장 : 최종 사용자별

  • 개요
    • 시장 규모·예측
  • 병원?진료소
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 외래 수술 센터
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제7장 플로 다이버 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 유형별
    • 북미의 시장 규모·예측 : 용도별
      • 북미의 다발성 두개내 다발성 동맥류 혈류 전환기 시장 : 부위별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽의 시장 규모·예측 : 유형별
    • 유럽 시장 규모·예측 : 용도별
      • 유럽의 다발성 두개내 다발성 동맥류 혈류 전환기 시장 : 부위별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 유형별
    • 아시아태평양의 시장 규모·예측 : 용도별
      • 아시아태평양의 다발성 두개내 동맥류 혈류 전환기 시장 : 부위별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 중국
      • 일본
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 유형별
    • LAMEA의 시장 규모·예측 : 용도별
      • LAMEA의 다발성 두개내 동맥류 혈류 전환기 시장 : 부위별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카 공화국
      • 기타 LAMEA

제8장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 주요 발전

제9장 기업 프로필

  • Acandis
  • BALT Extrusion SA
  • Medtronic
  • MicroPort Scientific Corporation
  • Microvention
  • Penumbra Inc.
  • Phenox
  • Stryker Neurovascular
  • Phenox GmbH
  • Johnson and Johnson
ksm 23.03.27

The global flow diverters market was valued at $251.4 million in 2021, and is projected to reach $1,041.9 million by 2031, registering a CAGR of 15.3% from 2022 to 2031. A cerebral or intracranial aneurysm is an abnormal focal dilation of an artery in the brain that results from a weakening of the inner muscular layer (the intima) of a blood vessel wall. For the treatment of cerebral aneurysms, flow diverters such as the surpass flow diverter, silk flow diverter, and pipeline embolization device. have been created. Instead of being implanted in the aneurysm sac, these endovascular devices are put inside the parent artery. They take advantage of altered hemodynamics at the aneurysm/parent vascular junction, which over time causes a progressive thrombosis of the aneurysm. The parent artery lumen is usually preserved together with perforators and side branches as a result of the subsequent inflammatory reaction, healing, and endothelial development that shrinks the aneurysm. Wide neck and massive aneurysms, which were previously incurable, can be treated by flow diverters.

The flow diverters market is driven by increase in the prevalence of cerebral or brain aneurysm, and rise in the prevalence of hypertension. Moreover, rise in the number of product launches and product approvals for flow diverters is anticipated to fuel the growth of flow diverters market. For instance, in August 2020, in the U.S., Stryker Corporation, medical equipment manufacturing company, announced the launch of Surpass Evolve Flow Diverter. It is a 64-wire cobalt chromium flow diverter designed for the treatment of unruptured giant and large wide-neck cerebral aneurysms. This approval is likely to help the company expand its neurovascular unit as well as its geographical presence. In addition, flow diverters are used to treat cerebral aneurysm, thus rise in the prevalence of cerebral aneurysm is anticipated to fuel the growth of the market. For instance, according to national institute of Neurological Disorders and Stroke, it was reported that, all cerebral aneurysms have the potential to rupture and cause bleeding within the brain or surrounding area. Approximately 30,000 Americans per year suffer a brain aneurysm rupture. Moreover, rise in the adoption of key strategies such as collaboration, acquisition, partnership and agreement by key players of flow diverters anticipated to fuel the growth of the market. In addition, technological advancement in the healthcare sector and increasing medical tourism are anticipated to drive the growth of flow diverters market. Moreover, rise in the awareness among the people regarding minimally invasive surgeries and increase in the disposable income among people in developing countries are anticipated to boost the growth of flow diverters market.

Geriatric population is more susceptible to orthopedic disorders, diabetes and fall injuries. These diseases causes rise in prevalence of pain. Thus, rise in number of geriatric populations increases the demand of flow diverters for treatment of cerebral aneurysm. Thus, this factor contributes to drive the growth of flow diverters market. In addition, Governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. health care spending grew by 9.7% from 2019 to 2020, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for in flow diverters application in different disease treatment, thereby boosting the market growth.

On the other hand, the side effects associated with flow diverters and high cost of flow diverters are anticipated to restrain the growth of the flow diverters market.  

The global flow diverters market is segmented on the basis of type, application, end user and region. On the basis of type, the market is divided into pipeline embolization device, silk flow diverter, surpass flow diverter, flow redirection endoluminal device and others. Others include electrical muscle stimulation, silk flow diverter and interferential current therapy (IC) P64, Silk & PED, PED & FRED. On the basis of application, market is classified into cerebral aneurysms, multiple intracranial aneurysms and others. Multiple intracranial aneurysms segment is divided into ophthalmic artery, middle cerebral and posterior communicating artery. Others include large aneurysm, giant aneurysm, blister like, and fusiform aneurysm. On the basis of end user, the market is bifurcated into hospitals and clinics and ambulatory surgical center. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global flow diverters market include Acandis, BALT Extrusion SA, InspireMD, Johnson and Johnson, Medtronic, MicroPort Scientific Corporation, Microvention, Penumbra Inc., Phenox, Stryker Neurovascular.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flow diverters market analysis from 2021 to 2031 to identify the prevailing flow diverters market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the flow diverters market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global flow diverters market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Pipeline embolization device
  • Silk flow diverter
  • Surpass flow diverter
  • Flow redirection endoluminal device
  • Others

By Application

  • Others
  • Cerebral aneurysms
  • Multiple Intracranial Aneurysms
    • Location
    • Ophthalmic artery
    • Middle cerebral
    • Posterior communicating artery

By End User

  • Hospital and clinics
  • Ambulatory surgical center

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Acandis
    • BALT Extrusion SA
    • Medtronic
    • MicroPort Scientific Corporation
    • Microvention
    • Penumbra Inc.
    • Phenox
    • Stryker Neurovascular
    • Phenox GmbH
    • Johnson and Johnson

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: FLOW DIVERTERS MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Pipeline embolization device
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Silk flow diverter
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Surpass flow diverter
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Flow redirection endoluminal device
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Others
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country

CHAPTER 5: FLOW DIVERTERS MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Cerebral aneurysms
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Multiple Intracranial Aneurysms
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
    • 5.3.4 Multiple Intracranial Aneurysms Flow Diverters Market by Location
      • 5.3.4.1 Ophthalmic artery Market size and forecast, by region
      • 5.3.4.2 Middle cerebral Market size and forecast, by region
      • 5.3.4.3 Posterior communicating artery Market size and forecast, by region
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: FLOW DIVERTERS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospital and clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Ambulatory surgical center
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: FLOW DIVERTERS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Application
      • 7.2.3.1 North America Multiple Intracranial Aneurysms Flow Diverters Market by Location
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Application
      • 7.3.3.1 Europe Multiple Intracranial Aneurysms Flow Diverters Market by Location
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Application
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Application
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
      • 7.4.3.1 Asia-Pacific Multiple Intracranial Aneurysms Flow Diverters Market by Location
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Application
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Application
      • 7.5.3.1 LAMEA Multiple Intracranial Aneurysms Flow Diverters Market by Location
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Acandis
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 BALT Extrusion SA
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Medtronic
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 MicroPort Scientific Corporation
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Microvention
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Penumbra Inc.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Phenox
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Stryker Neurovascular
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Phenox GmbH
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Johnson and Johnson
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제